¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-23
±³À°ÀÏÀÚ : 2018-11-23
±³À°Àå¼Ò : ¼­¿ïƯº°½Ã Àá½Ç ·Ôµ¥È£ÅÚ¿ùµå 3Ãþ Å©¸®½ºÅ»º¼·ë(¿Ü 1°³·ë)  
±³À°ÁÖÁ¦ : 2018 KALC International Conference
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ¹æÀ¯Áø
¿¬¶ôó : 02-6711-4767  
À̸ÞÀÏ : youjin@medrang.co.kr      
±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 17 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 300,000¿ø      
ºñ°í 30¸¸¿ø(Àü¹®ÀÇ, ±³¼ö) 25¸¸¿ø(Æç·Î¿ì, Àü°øÀÇ, °£È£»ç µî)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-23 Crystal 1,2,3 07:50~08:30 Navigating The Treatment Journey for Patients with Oncogene-Driven NSCLC  Takashi Seto(Kyushu Cancer Center, Japan) 
È޽Ġ11-23  08:30~09:00 Coffee Break  () 
±³À°½Ã°£ 11-23 Crystal 1,2,3 09:00~09:40 Neoantigen Study in Immuno-Oncology  Julie George(Department of Translational Genomics University of Cologne, Germany) 
±³À°½Ã°£ 11-23 Crystal 1,2,3 09:40~10:20 Lung Cancer Genomics - Post-Genomic Era  Marc Ladanyi(Memorial Sloan Kettering Cancer Center, USA) 
Åä·Ð 11-23 Crystal 1,2,3 10:20~10:30 Question and Answer  () 
È޽Ġ11-23 Crystal 1,2,3 10:30~11:00 Coffee Break  () 
±³À°½Ã°£ 11-23 Crystal 1,2,3 11:00~11:30 N2(+) NSCLC, Which Treatment Strategy Is Optimal?  Yong Chan Ahn(SungKyunkwan Univ., Korea) 
±³À°½Ã°£ 11-23 Crystal 1,2,3 11:30~12:00 Early Stage Lung Cancer Patients with Limited Lung Function  Hiroaki Nomori(Kameda Medical Center, Japan) 
±³À°½Ã°£ 11-23 Crystal 1,2,3 12:00~12:30 Small-Sized Lung Nodule, How to Approach and Treat  Hee Sun Park(Chungnam National Univ., Korea) 
±³À°½Ã°£ 11-23 Crystal 1,2,3 12:30~13:10 Nivolumab, Expert Strategies to Optimize I-O Treatment of Patients with NSCLC  David Heigener(LungenClinic Grosshansdorf GmbH, Germany) 
È޽Ġ11-23  13:10~13:40 Coffee Break  () 
Åä·Ð 11-23 Crystal 1 13:40~15:10 Oral Presentation ¥°  () 
Åä·Ð 11-23 Crystal 2 13:40~15:10 Oral Presentation ¥±  () 
±³À°½Ã°£ 11-23 Crystal 3 13:40~14:00 Surgery in High-Risk Patients  Hyeong Ryul Kim(Ulsan Univ., Korea) 
±³À°½Ã°£ 11-23 Emerald 13:40~14:10 More than Meets The Eye: Radiomics in Lung Cancer  Ho Yun Lee(SungKyunkwan Univ., Korea) 
±³À°½Ã°£ 11-23 Crystal 3 14:00~14:20 Surgical Treatment in Locally Advanced Lung Cancer  Elie Fadel(Hôpital Marie Lannelongue et Université Paris-Sud,France) 
±³À°½Ã°£ 11-23 Emerald 14:10~14:40 Imaging of Immunotherapy in Lung Cancer: Immune-Related Response and Toxicity Assessment  Gilbert R. Ferretti(Clinique universitaire de radiologie et imagerie médicale, France) 
±³À°½Ã°£ 11-23 Crystal 3 14:20~14:40 Role of Surgery in Advanced Lung Cancer  Young Tae Kim(Seoul National Univ.,Korea) 
±³À°½Ã°£ 11-23 Emerald 14:40~15:10 AI in Lung Cancer Imaging Clinical Perspective  Joon Beom Seo(Ulsan Univ., Korea) 
±³À°½Ã°£ 11-23 Crystal 3 14:40~15:00 Salvage Surgery in Lung Cancer  Hiroshi Date(Kyoto University, Japan) 
Åä·Ð 11-23 Crystal 3 15:00~15:10 Question and Answer  () 
È޽Ġ11-23  15:10~15:40 Coffee Break  () 
Åä·Ð 11-23 Crystal 1 15:40~17:10 Oral Presentation ¥²  () 
Åä·Ð 11-23 Crystal 2 15:40~17:10 Oral Presentation ¥³  () 
±³À°½Ã°£ 11-23 Crystal 3 15:40~16:10 Integrating radiotherapy and immunotherapy for the treatment of non-small cell lung carcinoma  Eric Ko(Weill Cornell Medical College, USA) 
±³À°½Ã°£ 11-23 Crystal 3 16:10~16:40 Promise of Combining Radiation Therapy and Immunotherapy  Encouse B. Golden(University of California, USA) 
±³À°½Ã°£ 11-23 Crystal 3 16:40~17:10 Combination of SBRT with Immunotherapy for Lung Cancer Patients  O Kyu Noh(Ajou Univ., Korea) 
±³À°½Ã°£ 11-23 Emerald 15:40~16:10 Pathogenesis and Treatment of NUT Midline Carcinoma  Christopher Alexander French(Brigham and Women) 
±³À°½Ã°£ 11-23 Emerald 16:10~16:40 Understanding and Targeting the Key Pathways Underlying Chemoresistance and Tumor Relapse  Ho Young Lee(Seoul National Univ., Korea) 
±³À°½Ã°£ 11-23 Emerald 16:40~17:10 Structural Variations in Lung Cancer Genomes  Young Seok Ju(KAIST, Korea) 
È޽Ġ11-23 Emerald 17:10~17:40 Coffee Break  () 
±³À°½Ã°£ 11-23 Crystal 1,2,3 17:40~18:40 Grounreaking Efficacy of Osimertinib as a New SoC for EGFRm NSCLC Management  James Yang(National Taiwan University Hospital, Taiwan) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¸·Îº´¿ø È£½ºÇǽº Àü¹®Àη ǥÁر³À° : 2018-11-23
´ÙÀ½±Û 2018³âµµ Çѱ¹ÀÇÇб³À°ÇÐȸ ´ë±¸°æºÏÁöȸ ÀÇÇб³À° ½ÉÆ÷Áö¾ö : 2018-11-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 47 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 36 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 30 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷